stockrow
Friday 6 November 2026
Export MMED’s income statement to Excel — free account
MiniMed Group, Inc.
MMED Healthcare Medical Instruments & Supplies
MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.
18.23
1.06
−5.50%
Follow MMED
Alert me
MiniMed Group, Inc. (MMED) Revenue
MiniMed Group, Inc.'s revenue for fiscal 2026 was $3.1B, up 14.3% from $2.7B in fiscal 2025. Over the twelve months to 31 July 2026 it was $3.0B. MiniMed Group, Inc. ranks 15th of 47 Medical Instruments & Supplies companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2026 | $3.1B | 14.25% |
| FY2025 | $2.7B | 9.96% |
| FY2024 | $2.5B | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jul 2026 | $843.0M | 6.71% |
| Jan 2026 | $790.0M | 9.27% |
| Jul 2025 | $723.0M | 5.24% |
| Jan 2025 | $687.0M | — |
Revenue against peers
| Company | Revenue |
|---|---|
| BLCO Bausch + Lomb Corporation compare | $5.4B |
| MMED MiniMed Group, Inc. | $3.0B |
| NVST Envista Holdings Corporation compare | $2.9B |
| TFX Teleflex Incorporated compare | $2.3B |
| ICUI ICU Medical, Inc. compare | $2.2B |
| MMSI Merit Medical Systems, Inc. compare | $1.6B |
| STVN Stevanato Group S.p.A. compare | $1.4B |
| ATRC AtriCure, Inc. compare | $589.8M |
| PLSE Pulse Biosciences, Inc compare | $1.5M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on MMED
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Shares outstanding
- Book value per share
- The full statement